What's new

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 32, Status: Authorised

Mar 31, 2025 - 15:52
 0
Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 32, Status: Authorised
Human medicines European public assessment report (EPAR): Zebinix, eslicarbazepine acetate, Date of authorisation: 21/04/2009, Revision: 32, Status: Authorised
Read More

Tags:

Previous Article

Google DeepMind’s drug discovery spin-off Isomorphic Labs raises $600mn

Next Article

We asked 100 utility program leaders for their top challenges and opportunities....

Related Posts

Herbal medicinal product: Cynarae folium, Cynara cardunculus L.,syn. C. scolymus L., C: ongoing call for scientific data

Herbal medicinal product: Cynarae folium, Cynara cardun...

Mar 13, 2025  0

Human medicines European public assessment report (EPAR): Eurneffy, epinephrine, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Omvoh, Mirikizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: P/0534/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 13, 2025  0